Opportunities and challenges in application of artificial intelligence in pharmacology

Abstract

Artificial intelligence (AI) is a machine science that can mimic human behaviour like intelligent analysis of data. AI functions with specialized algorithms and integrates with deep and machine learning. Living in the digital world can generate a huge amount of medical data every day. Therefore, we need an automated and reliable evaluation tool that can make decisions more accurately and faster. Machine learning has the potential to learn, understand and analyse the data used in healthcare systems. In the last few years, AI is known to be employed in various fields in pharmaceutical science especially in pharmacological research. It helps in the analysis of preclinical (laboratory animals) and clinical (in human) trial data. AI also plays important role in various processes such as drug discovery/manufacturing, diagnosis of big data for disease identification, personalized treatment, clinical trial research, radiotherapy, surgical robotics, smart electronic health records, and epidemic outbreak prediction. Moreover, AI has been used in the evaluation of biomarkers and diseases. In this review, we explain various models and general processes of machine learning and their role in pharmacological science. Therefore, AI with deep learning and machine learning could be relevant in pharmacological research.

Assessment of stress among pharmacy educators: Validation of the faculty stress index and 2-year cross-sectional follow-up in a Lebanese pharmacy school

“…The current upgraded version used in this analysis includes an additional area for satisfaction with online courses, which was not present in the previous versions of the FSI, and which appeared necessary to add given the shift to remote education that accompanied the pandemic. This new dimension added to the questionnaire may appear particularly relevant in the era of digitally enriched education, and it may be tempting to further explore and follow up, especially in line with the huge shift in digital pedagogies, artificial intelligence, and data science, all expected to have a profound effect on education (Walsh, 2020;Kumar et al, 2023). Also, inquiry about stress coping strategies among pharmacy faculty was an addition to published surveys and was helpful in getting insights about how faculty tend to undergo self-remediation and cope with adversities of the workplace as well as the daunting situation the country was and is still to face.…”

Artificial intelligence and machine learning for clinical pharmacology

“…AI will also likely transform areas of specialist interest for many clinical pharmacologists, such as drug discovery and development, 19,20 clinical trials, 21 medicines management, 22 personalized medicine and precision dosing, 23,24 pharmacogenomics, 25 pharmacovigilance and adverse drug reactions, 26 and clinical toxicology 27 (Figure 1). The use of AI in preclinical pharmacology is extensively covered elsewhere 28,29 …”

Phenolic Derivatives with Anti‐Acetylcholinesterase Inhibitory Activities fromGaleola nudifoliain Vietnam

“…Alzheimer's disease (AD) is a prevalent neurological disorder representing the most frequently encountered type of dementia [1,2] . The primary symptoms of AD encompass cognitive dysfunction, degeneration, and the decline of basal forebrain cholinergic innervation [2–4] .…”